✦ LIBER ✦

Effects of a ?1-selective adrenergic agonist in normal human volunteers

✍ Scribed by Meurer, K. A. ;Lang, R. ;Hombach, V. ;Helber, A.

Publisher: Springer-Verlag
Year: 1980
Tongue: English
Weight: 356 KB
Volume: 58
Category: Article
ISSN: 1432-1440
DOI: 10.1007/bf01477508

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immediate haemodynamic effects of prenal

Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers

✍ T. Lysbo Svendsen; O. J. Hartling; J. Trap-Jensen 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 402 KB

Discovery of a Novel, Potent and Selecti

Discovery of a Novel, Potent and Selective Human β3-Adrenergic Receptor Agonist.

✍ Yutaka Nakajima; Hitoshi Hamashima; Ken-Ichi Washizuka; Yasuyo Tomishima; Hiroak 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 10 KB 👁 1 views

Reinforcing and subjective effects of ca

Reinforcing and subjective effects of caffeine in normal human volunteers

✍ K. N. Stern; L. D. Chait; C. E. Johanson 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 934 KB

PHARMACOKINETICS OF MDL 26 479, A NOVEL

PHARMACOKINETICS OF MDL 26 479, A NOVEL BENZODIAZEPINE INVERSE AGONIST, IN NORMAL VOLUNTEERS

✍ DORIS K. ROBBINS; SAM J. HUTCHESON; TERRY D. MILLER; VICTOR I. GREEN; VIJAY O. B 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

MDL 26 479 is a new drug undergoing clinical evaluation for the treatment of depression and for memory loss associated with Alzheimer's disease. As part of a dose tolerance trial, the single-(SD) and multiple-dose (MD) pharmacokinetics of MDL 26 479 were evaluated in healthy male volunteers. SDs ran

Dose-response relationship in normal sub

Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects

✍ S. Rasmussen; P. -F. Høilund-Carlsen; B. Hesse; O. J. Hartling; J. Fabricius; H. 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 578 KB

Design of a novel pyrrolidine scaffold u

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonists

✍ Gregori J. Morriello; Harvey R. Wendt; Alka Bansal; Jerry Di Salvo; Scott Feighn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 822 KB

A novel class of human b 3 -adrenergic receptor agonists was designed in effort to improve selectivity and metabolic stability versus previous disclosed b 3 -AR agonists. As observed, many of the b 3 -AR agonists seem to need the acyclic ethanolamine core for agonist activity. We have synthesized de